Position in NBIX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$2,503,324
+$1,382,612 QoQ
Shares Held
14,853
+74.6% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#286
of 774 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Allworth Financial LP holds $7,771,550 across 48 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (32.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
This page
|
14,853 | $2,503,324 | |
| 2 | SUPN |
Supernus Pharmaceuticals, Inc.
|
50,669 | $2,356,615 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
1,167 | $632,315 | |
| 4 | ZTS |
Zoetis Inc.
|
6,658 | $478,443 | |
| 5 | VTRS |
Viatris Inc
|
18,367 | $291,667 | |
| 6 | TAK |
Takeda Pharmaceutical Co Ltd
|
13,516 | $216,661 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
8,616 | $212,039 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
4,826 | $174,701 |
All Filings in NBIX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,503,324 | 14,853 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,120,712 | 8,507 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $913,243 | 6,439 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $703,163 | 5,009 | Shares | Sole | 2025-12-02 | |
| 2025-06-30 | $374,556 | 2,980 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $14,931 | 135 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $22,659 | 166 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $15,669 | 136 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $32,214 | 234 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $12,136 | 88 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $11,594 | 88 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $6,300 | 56 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $7,072 | 75 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $7,793 | 77 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $6,210 | 52 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $5,629 | 53 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,729 | 28 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $1,781 | 19 | Shares | Sole | 2022-04-22 | |
| 2021-12-31 | $9,113 | 107 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $11,892 | 124 | Shares | Sole | 2021-11-02 | |
| No filing history on record for this holder in this stock. | ||||||